The Spectrum of Caregiving in Palliative Care for Serious, Advanced, Rare Diseases: Key Issues and Research Directions

Abstract

Rare diseases are often life-limiting conditions, the majority of which require constant caregiving needs. The realization of a spectrum of palliative care throughout the trajectory of rare diseases could ensure individualized and caregiver-focused approaches to the care of patients and families. In June 2015, the National Institute of Nursing Research (NINR), the lead institute at the National Institutes of Health for end-of-life research, in conjunction with the National Center for Advancing Translational Sciences, Office of Rare Diseases Research (ORDR) held an interdisciplinary workshop on the unique challenges of caregiving and palliative care in adult and pediatric rare diseases. The panel identified gaps in current knowledge, and afforded suggestions for research opportunities in palliative care science to improve the care of individuals with serious, advanced, rare diseases and their caregivers. This meeting provided an in-depth opportunity to incorporate new concepts into palliative and end-of-life care for individuals with a range of rare diseases and their caregivers. This report presents a summary of the workshop.

Parenting in Childhood Life-Threatening Illness: A Mixed-Methods Study

“…43,67 Finally, models for addressing social support needs alongside illness-directed care, a major need identified by the Institute of Medicine, are needed. 12 Elucidating the impact of simultaneous stressors 10,67,68 and potential stress-buffering resources 69,70 can inform services geared toward particular family strengths and demands.…”

Future cancer research priorities in the USA: a Lancet Oncology Commission

“…The US National Institutes of Nursing Research does a lot of research on end-of-life issues and have identified the following research gaps: living with uncertainty; the costs of caregiving; communication; interventions for ethnically and culturally diverse populations; and transitions in care. 214,215 We have much to learn from our patients 216,217 and our European colleagues 218 in this area. Although some foundations fund end-of-life research, 219 overall federal funding for end-of-life research is small and should be expanded.…”

An Overview of Benefits and Challenges of Rare Disease Biobanking in Africa, Focusing on South Africa

“…16 The required multidisciplinary care is often uncoordinated, placing an additional burden on the patient. 3,4,17 A key challenge preventing RDs from being adequately addressed in LMIC is the slow development of RD diagnosis and research in the context of global collaboration. 16 The paucity of characterized local genetic variants and the often complex relationship between phenotype and genotype require attention in these LMIC.…”